Literature DB >> 8691514

Influence of patient-related variables on the outcome of carotid endarterectomy.

J Golledge1, R Cuming, D K Beattie, A H Davies, R M Greenhalgh.   

Abstract

PURPOSE: Variability in outcome after carotid endarterectomy is well recognized. This study examines the importance of patient-related factors in determining outcome.
METHODS: Four hundred and sixty consecutive patients undergoing carotid endarterectomy for symptomatic severe (60% to 99%) internal carotid stenosis performed by one vascular surgeon have been studied prospectively. Patients were followed-up at 3, 6, 9, and 12 months and then yearly. Pre-, intra-, and perioperative details and follow-up information were entered on a database.
RESULTS: Multiple logistic regression identified a number of factors significantly associated with death and stroke. A history of crescendo transient ischemic attacks (TIAs) (p = 0.003, p = 0.0002) and being female (p = 0.03, p = 0.0001) were associated with both perioperative death and stroke within 30 days of operation, respectively. Deaths between 1 and 36 months were associated with ischemic heart disease (p = 0.03) and diabetes (p = 0.04), whereas stroke was associated with small internal carotid diameter (p = 0.02). The importance of symptoms at presentation on outcome was further emphasized by life-table analysis. In 98% of patients with amaurosis fugax, only 67% of those with crescendo TIAs were alive at 18 months (p < 0.01). The survival of patients with amaurosis was significantly better than those with TIAs (p < 0.01), transient stroke (p < 0.01), and progressive, stroke (p < 0.05). Similarly, postoperative stroke was significantly more common for patients with crescendo TIAs than those with amaurosis (p < 0.01), established stroke (p < 0.05), and TIA (p < 0.05). Transient stroke was associated with a poor outcome, with only 66% of patients being alive in 36 months and 14% having suffered a stroke (p < 0.05 compared with established stroke).
CONCLUSION: Presenting symptoms significantly predict outcome after carotid endarterectomy. This should be considered both in patient selection and comparison of patient series.

Entities:  

Mesh:

Year:  1996        PMID: 8691514     DOI: 10.1016/s0741-5214(96)70152-0

Source DB:  PubMed          Journal:  J Vasc Surg        ISSN: 0741-5214            Impact factor:   4.268


  7 in total

1.  Characteristics of carotid artery disease (CAD) and presenting cerebrovascular symptoms in an aged group.

Authors:  Qingwei Chen; Ying Liu; Linlin Pei; Dazhi Ke; Guiqiong Li; Wei Deng; Wuwei Yao
Journal:  Int J Cardiovasc Imaging       Date:  2008-10-14       Impact factor: 2.357

2.  Carotid endarterectomy in women: challenging the results from ACAS and NASCET.

Authors:  M A Mattos; D S Sumner; W T Bohannon; J Parra; R B McLafferty; L A Karch; D E Ramsey; K J Hodgson
Journal:  Ann Surg       Date:  2001-10       Impact factor: 12.969

3.  Computerised audit of carotid endarterectomy: audit loopholes closed?

Authors:  D R Lewis; C D Irvine; S E Cole; C McGrath; R N Baird; P M Lamont
Journal:  Ann R Coll Surg Engl       Date:  1997-11       Impact factor: 1.891

4.  Tissue factor expression in the symptomatic carotid plaque.

Authors:  Hani Abdul-Jabar; Abbas Rashid; Amir Sadri; Trevor Paes
Journal:  J Clin Med Res       Date:  2009-07-23

5.  Treatment Outcome of Carotid Artery Stenting Underwent within 14 Days of Stroke Onset - Consideration of Safety and Efficacy of Urgent Carotid Artery Stenting for Neurologically Progressing Patients.

Authors:  Yasuhisa Kanematsu; Junichiro Satomi; Kazuyuki Kuwayama; Izumi Yamaguchi; Shotaro Yoshioka; Tomoya Kinouchi; Yoshiteru Tada; Nobuaki Yamamoto; Shunji Matsubara; Koichi Satoh; Shinji Nagahiro
Journal:  Neurol Med Chir (Tokyo)       Date:  2017-04-06       Impact factor: 1.742

6.  Comparative Effectiveness of Carotid Endarterectomy vs Initial Medical Therapy in Patients With Asymptomatic Carotid Stenosis.

Authors:  Salomeh Keyhani; Eric M Cheng; Katherine J Hoggatt; Peter C Austin; Erin Madden; Paul L Hebert; Ethan A Halm; Ayman Naseri; Jason M Johanning; Danielle Mowery; Wendy W Chapman; Dawn M Bravata
Journal:  JAMA Neurol       Date:  2020-09-01       Impact factor: 18.302

7.  Personalised Approach to Diagnosing and Managing Ischemic Stroke with a Plasma-Soluble Urokinase-Type Plasminogen Activator Receptor.

Authors:  Katarzyna Śmiłowska; Marek Śmiłowski; Robert Partyka; Danuta Kokocińska; Przemysław Jałowiecki
Journal:  J Pers Med       Date:  2022-03-14
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.